ASX
Alterity Therapeutics Limited
ATH:ASX•Healthcare
Sensitive ASX Announcement
ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder
Published: 30/05/23, 01:32pm (AEST)•3 pages